Post-traumatic stress disorder (PTSD)

We want to find better ways to support people suffering with mental health challenges, and we believe we’re onto something important.

Post-traumatic stress disorder (PTSD) is a mental health condition resulting from trauma – events that are very stressful or frightening. Symptoms include nightmares, flashbacks, difficulty sleeping and concentrating, and feelings of isolation, irritability, and guilt.1

Over 300 million people will experience PTSD at some point in their lives, yet only 20-30% of patients treated with currently approved interventions will make a full recovery.

About our PTSD study

We are conducting a phase 2 clinical trial of COMP360 psilocybin treatment in people who suffer with PTSD as a result of trauma experienced as adults. The study will include 20 participants, and is taking place at The Institute of Psychiatry, Psychology & Neuroscience at King's College London and Icahn School of Medicine at Mount Sinai.


Both sites are currently recruiting patients to join the study – for more information on how to join, click here.

Video title
Dr Guy Goodwin, Chief Medical Officer, explains why we’ve launched a study of COMP360 psilocybin treatment in PTSD

 

1https://www.nhs.uk/mental-health/conditions/post-traumatic-stress-disorder-ptsd/

We are keen to progress research that has the potential to change mental health outcomes.

 View our pipeline